Historical record - last NADAC publication: 2/22/2017
Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0370 per EA under NDC 65862004405. Its NADAC has been published 170 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Lisinopril and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 20 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862004405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/22/2017
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077606On Market Since
3/14/2006
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0370 per EA |
|---|---|
| All-time high | $0.0461 (Apr 16, 2014) |
| All-time low | $0.0328 (Jun 22, 2016) |
| Median price | $0.0370 |
| Average price | $0.0387 |
| Largest weekly change | -9.7% (Nov 23, 2016) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.0370 per EA (NDC 65862004405), effective Feb 22, 2017.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 13.2%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.0328 (Jun 22, 2016) to a high of $0.0461 (Apr 16, 2014), with a median of $0.0370 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, is $0.0370 per EA — about 0% below LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 65862004405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification